Hu Jang Lee Selected Research

Hu Jang Lee Research Topics

Disease

31	Infections 08/2023 - 11/2011
26	Brucellosis (Malta Fever) 08/2023 - 08/2012
3	Inflammation (Inflammations) 01/2019 - 02/2017
3	Bacterial Infections (Bacterial Infection) 10/2018 - 09/2014
3	Bovine Brucellosis (Bang's Disease) 04/2016 - 06/2012
2	Persistent Infection 04/2023 - 03/2016
1	Virus Diseases (Viral Diseases) 04/2023
1	Necrosis 01/2023
1	Splenomegaly 10/2019
1	Salmonella Infections (Salmonellosis) 08/2017
1	Communicable Diseases (Infectious Diseases) 01/2013
1	Body Weight (Weight, Body) 10/2007
1	Carcinogenesis 09/2004

Drug/Important Bio-Agent (IBA)

8	Interleukin-10 (Interleukin 10)IBA 08/2023 - 01/2018
7	Proteins (Proteins, Gene)FDA Link 02/2019 - 09/2014
6	VaccinesIBA 02/2019 - 01/2013
5	CytokinesIBA 08/2023 - 01/2018
5	Interleukin-6 (Interleukin 6)IBA 08/2023 - 01/2018
4	Subunit VaccinesIBA 06/2020 - 02/2015
3	Interleukin-12 (IL 12)IBA 05/2020 - 10/2019
3	Therapeutic UsesIBA 06/2018 - 11/2011
3	Actins (F Actin)IBA 01/2018 - 02/2016
2	ginsenoside Rg3IBA 04/2023 - 03/2017
2	IronIBA 01/2023 - 01/2018
2	LipidsIBA 01/2021 - 09/2013
2	Recombinant ProteinsIBA 02/2019 - 01/2016
2	Gallic AcidIBA 06/2018 - 08/2017
2	Tannic Acid FDA Link 01/2018 - 08/2017
2	EnzymesIBA 01/2018 - 06/2015
2	TanninsIBA 08/2017 - 01/2012
2	Membrane Proteins (Integral Membrane Proteins)IBA 06/2015 - 06/2012
2	Virulence Factors (Pathogenicity Factors)IBA 01/2013 - 08/2012
2	Galla RhoisIBA 01/2012 - 11/2011
1	sodium propionateIBA 08/2023
1	ResveratrolIBA 04/2023
1	Sirtuin 1IBA 04/2023
1	3,3',4,5'-tetrahydroxystilbeneIBA 04/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinIBA 09/2021
1	lauric acid (dodecanoic acid)IBA 09/2021
1	Phospholipases A2 (Phospholipase A2)IBA 03/2021
1	Arachidonic Acid (Vitamin F)IBA 03/2021
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2021
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2021
1	NitritesIBA 05/2020
1	Linoleic Acid (Linoleate)IBA 05/2020
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 03/2020
1	Interferon-gamma (Interferon, gamma)IBA 11/2019
1	Interleukin-4 (Interleukin 4)IBA 11/2019
1	plerixafor FDA Link 10/2019
1	Chemokine ReceptorsIBA 10/2019
1	Transcription Factors (Transcription Factor)IBA 05/2019
1	Interleukin-1 (Interleukin 1)IBA 05/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	AnthraquinonesIBA 10/2018
1	Emodin (Archin)IBA 10/2018
1	Phosphotransferases (Kinase)IBA 06/2018
1	InterferonsIBA 01/2018
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2018
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	AntigensIBA 01/2018
1	Lipocalin-2IBA 01/2018
1	Food Additives (Food Additive)IBA 08/2017
1	SaponinsIBA 03/2017
1	Volatile Oils (Essential Oils)IBA 02/2017
1	NocodazoleIBA 02/2017
1	platelet activating factor receptorIBA 04/2016
1	Platelet Activating FactorIBA 04/2016
1	LipopolysaccharidesIBA 04/2016
1	bacterioferritinIBA 04/2016
1	AntibodiesIBA 04/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2016
1	Maltose-Binding ProteinsIBA 01/2016
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2016
1	ImmunosorbentsIBA 06/2015
1	4-boronic acid benzophenoneIBA 09/2014
1	ClathrinIBA 09/2013
1	Ketamine FDA LinkGeneric 01/2013
1	Lipoproteins (Lipoprotein)IBA 01/2013
1	Messenger RNA (mRNA)IBA 02/2012
1	salinomycinIBA 01/2012
1	PowdersIBA 01/2012
1	Ethanol (Ethyl Alcohol)IBA 11/2011
1	ceftiofurIBA 10/2007
1	7-hydroxy-3-methoxy-cadaleneIBA 09/2004

Therapy/Procedure

1	Therapeutics 01/2020
1	Microspheres (Microsphere) 06/2012
1	Aftercare (After-Treatment) 10/2007